Beacon Investment Advisory Services, Inc. Gilead Sciences, Inc. Transaction History
Beacon Investment Advisory Services, Inc.
- $2.29 Billion
- Q1 2024
A detailed history of Beacon Investment Advisory Services, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 75,864 shares of GILD stock, worth $5.22 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
75,864
Previous 74,371
2.01%
Holding current value
$5.22 Million
Previous $6.02 Million
7.75%
% of portfolio
0.24%
Previous 0.28%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
1,883Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.42 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$7.89 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.81 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.21 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$3.97 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $86.2B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...